Bio Impact Capital LLC Neogenomics Inc Transaction History

Bio Impact Capital LLC

  • $641 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$12.15 - $35.28 $58,915 - $171,072
-4,849 Reduced 3.45%
135,573 $1.65 Million
Q4 2021

Feb 11, 2022
SELL
$30.49 - $48.49 $276,910 - $440,386
-9,082 Reduced 6.07%
140,422 $4.79 Million
Q3 2021

Nov 15, 2021
BUY
$41.66 - $52.52 $6.23 Million - $7.85 Million
149,504 New
149,504 $7.21 Million

Others Institutions Holding NEO

# of Institutions
296
Shares Held
125M
Call Options Held
698K
Put Options Held
116K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.7B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email